Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors

被引:8
|
作者
Arya, Rimanshee [1 ,2 ]
Prashar, Vishal [1 ]
Kumar, Mukesh [1 ,2 ]
机构
[1] Bhabha Atom Res Ctr, Radiat Biol Sr Hlth Sci Div, Prot Crystallog Sect, Mumbai 400085, Maharashtra, India
[2] Homi Bhabha Natl Inst, Mumbai 400094, Maharashtra, India
关键词
SARS-CoV-2; COVID-19; Papain-like protease; Enzyme activity; Aggregation; Stability; PAPAIN-LIKE PROTEASE; RESPIRATORY SYNDROME CORONAVIRUS;
D O I
10.1007/s12033-021-00383-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Because of the essential roles of SARS-CoV-2 papain-like protease (PLpro) in the viral polyprotein processing and suppression of host immune responses, it is a crucial target for drug discovery against COVID-19. To develop robust biochemical methodologies for inhibitor screening against PLpro, extensive characterization of recombinant protein is important. Here we report cloning, expression, and purification of the recombinant SARS-CoV-2 PLpro, and explore various parameters affecting its stability and the catalytic activity. We also report the optimum conditions which should be used for high-throughput inhibitor screening using a fluorogenic tetrapeptide substrate.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors
    Rimanshee Arya
    Vishal Prashar
    Mukesh Kumar
    [J]. Molecular Biotechnology, 2022, 64 : 1 - 8
  • [2] High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
    Yao Zhao
    Xiaoyu Du
    Yinkai Duan
    Xiaoyan Pan
    Yifang Sun
    Tian You
    Lin Han
    Zhenming Jin
    Weijuan Shang
    Jing Yu
    Hangtian Guo
    Qianying Liu
    Yan Wu
    Chao Peng
    Jun Wang
    Chenghao Zhu
    Xiuna Yang
    Kailin Yang
    Ying Lei
    Luke WGuddat
    Wenqing Xu
    Gengfu Xiao
    Lei Sun
    Leike Zhang
    Zihe Rao
    Haitao Yang
    [J]. Protein & Cell, 2021, 12 (11) : 877 - 888
  • [3] High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
    Zhao, Yao
    Du, Xiaoyu
    Duan, Yinkai
    Pan, Xiaoyan
    Sun, Yifang
    You, Tian
    Han, Lin
    Jin, Zhenming
    Shang, Weijuan
    Yu, Jing
    Guo, Hangtian
    Liu, Qianying
    Wu, Yan
    Peng, Chao
    Wang, Jun
    Zhu, Chenghao
    Yang, Xiuna
    Yang, Kailin
    Lei, Ying
    Guddat, Luke W.
    Xu, Wenqing
    Xiao, Gengfu
    Sun, Lei
    Zhang, Leike
    Rao, Zihe
    Yang, Haitao
    [J]. PROTEIN & CELL, 2021, 12 (11) : 877 - 888
  • [4] Inhibitors of SARS-CoV-2 PLpro
    Calleja, Dale J.
    Lessene, Guillaume
    Komander, David
    [J]. FRONTIERS IN CHEMISTRY, 2022, 10
  • [5] High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain
    Dasovich, Morgan
    Zhuo, Junlin
    Goodman, Jack A.
    Thomas, Ajit
    McPherson, Robert Lyle
    Jayabalan, Aravinth Kumar
    Busa, Veronica F.
    Cheng, Shang-Jung
    Murphy, Brennan A.
    Redinger, Karli R.
    Alhammad, Yousef M. O.
    Fehr, Anthony R.
    Tsukamoto, Takashi
    Slusher, Barbara S.
    Bosch, Jurgen
    Wei, Huijun
    Leung, Anthony K. L.
    [J]. ACS CHEMICAL BIOLOGY, 2022, 17 (01) : 17 - 23
  • [6] High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior
    Yang, Zhiwei
    Cai, Xinhui
    Ye, Qiushi
    Zhao, Yizhen
    Li, Xuhua
    Zhang, Shengli
    Zhang, Lei
    [J]. CURRENT DRUG TARGETS, 2023, 24 (06) : 532 - 545
  • [7] High throughput screening for SARS-CoV-2 helicase inhibitors
    Otsuka, Yuka
    Kim, Eunjung
    Krueger, Austin
    Shumate, Justin
    Wang, Chao
    Bdiri, Bilel
    Ullah, Sultan
    Park, Hajeung
    Scampavia, Louis
    Bannister, Thomas D.
    Chung, Donghoon
    Spicer, Timothy P.
    [J]. SLAS DISCOVERY, 2024, 29 (06)
  • [8] SARS-CoV-2 replicon for high-throughput antiviral screening
    Zhang, Qiu-Yan
    Deng, Cheng-Lin
    Liu, Jing
    Li, Jia-Qi
    Zhang, Hong-Qing
    Li, Na
    Zhang, Ya-Nan
    Li, Xiao-Dan
    Zhang, Bo
    Xu, Yi
    Ye, Han-Qing
    [J]. JOURNAL OF GENERAL VIROLOGY, 2021, 102 (05):
  • [9] High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
    Zang, Yi
    Su, Mingbo
    Wang, Qingxing
    Cheng, Xi
    Zhang, Wenru
    Zhao, Yao
    Chen, Tong
    Jiang, Yingyan
    Shen, Qiang
    Du, Juan
    Tan, Qiuxiang
    Wang, Peipei
    Gao, Lixin
    Jin, Zhenming
    Zhang, Mengmeng
    Li, Cong
    Zhu, Ya
    Feng, Bo
    Tang, Bixi
    Xie, Han
    Wang, Ming-Wei
    Zheng, Mingyue
    Pan, Xiaoyan
    Yang, Haitao
    Xu, Yechun
    Wu, Beili
    Zhang, Leike
    Rao, Zihe
    Yang, Xiuna
    Jiang, Hualiang
    Xiao, Gengfu
    Zhao, Qiang
    Li, Jia
    [J]. PROTEIN & CELL, 2023, 14 (01) : 17 - 27
  • [10] High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor
    Brown, Alistair S.
    Ackerley, David F.
    Calcott, Mark J.
    [J]. MOLECULES, 2020, 25 (20):